Emmanuelle Charpentier is the Founding and Acting Director of the Max Planck Unit for the Science of Pathogens and an Honorary Professor at Humboldt University. She completed her undergraduate studies at the Pierre and Marie Curie University, which is now known as the Faculty of Science at Sorbonne University. She went on to earn a research doctorate from the Institut Pasteur.
Charpentier is well known for her collaboration with Jennifer Doudna on decoding the molecular mechanisms of the CRISPR/Cas9 bacterial immune system. Her work on CRISPR has enabled scientists to edit the genome using Cas9.
For her work on CRISPR, she has received the BBVA Foundation Frontiers of Knowledge Award, the Gruber Foundation International Prize in Genetics, the Leibniz Prize, the Kavli Prize and the Breakthrough Prize in Life Sciences, the Novozymes Prize, the Bijvoet Medal of the Bijvoet Center for Biomolecular Research at Utrecht University, and most recently, the Scheele Award of the Swedish Pharmaceutical Society.
Charpentier is an elected member of the National Academy of Technologies of France, the German National Academy of Science and Engineering Acatech, and the French Académie des sciences. She is an elected foreign member of the Royal Swedish Academy of Engineering Sciences and the National Academy of Sciences. In 2020, Charpentier earned the Nobel Prize in Chemistry, alongside Jennifer Doudna, “for the development of a method for genome editing.”
Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics and biochemistry. Since 2015, she has been a Director at the Max Planck Institute for Infection Biology in Berlin, Germany. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens.Source: Wikipedia
University medical center in the city of Hanoverview profile
Public university in Vienna, Austriaview profile
University in Swedenview profile